Immuneel Therapeutics

Immuneel Therapeutics outlines plans to scale manufacturing, advance its cell and gene therapy pipeline, commercialise Qartemi…

In a major milestone in Indian oncology care, Immuneel Therapeutics’ Made-In-India CAR T-cell therapy has delivered the country’s…

Collaboration to evaluate AI-led discovery across antibodies, ADCs and gene therapy platforms

At Scale-Up Health, an initiative by Eight Roads Ventures, industry leaders highlighted that the challenge is no longer scientific…

According to GlobalData’s Drugs Database, blood cancers account for over half of all CAR-Ts in the active pipeline* and make up…

Budget provisions focus on customs duty exemptions, R&D funding, and healthcare infrastructure expansion

Amit Mookim, CEO, Immuneel Therapeutics urges the govt to focus on establishing a strong compliance framework and expediting…

Industry leaders share their expectations from the upcoming Union budget 2025-26. Increased allocation for R&D and…

Mookim will focus on establishing partnerships with providers, practitioners, and public health, and delivering current CART…

In this video, Arun Anand, COO, Immuneel Therapeutics and Dr Bruce Levine, of the University of Pennsylvania Perelman School of…